Diagnostic Algorithm for ADHD
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to help doctors diagnose ADHD in children and teens using the MindTension sensor, which analyzes specific responses to sound. The goal is to determine the accuracy of this method compared to traditional diagnostic tools. Participants will be divided into two groups: those with ADHD symptoms and those without any diagnosed disorders. Children aged 6 to 17 who show signs of ADHD or have no diagnosed mental health issues, and who haven't recently taken certain medications, may be suitable for this study. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance ADHD diagnosis methods.
Will I have to stop taking my current medications?
If you are currently taking stimulant medications, you will need to stop them for 3 days before testing. If you are on other psychotropic medications that can't be stopped in 3 days, you may not be eligible to participate.
What prior data suggests that the MT1 algorithm and MindTension biometric sensor device are safe for diagnosing ADHD in youth?
Research has shown that the MT1 auditory startle response patterns analysis algorithm aids doctors in diagnosing ADHD in young people by analyzing their reactions to certain sounds. It is not a treatment or medication, so it poses no risk of drug side effects.
The MindTension device, which operates with the MT1 algorithm, measures muscle responses to sounds. This non-invasive process does not involve surgery or entering the body. To date, no negative effects have been reported from using this diagnostic tool.
As this study tests a diagnostic tool rather than a new drug or treatment, the primary safety concern is the device's comfort and ease of use. Current evidence suggests that the device is well-tolerated, as it measures responses without causing harm.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a novel approach to diagnosing ADHD using the MT1 auditory startle response patterns analysis algorithm. Unlike typical diagnostic methods that rely heavily on interviews and questionnaires, this algorithm analyzes auditory startle responses, offering a potentially objective and measurable indicator of ADHD. This could lead to faster, more accurate diagnoses, reducing reliance on subjective assessments and potentially improving treatment outcomes by identifying the condition earlier.
What evidence suggests that the MT1 algorithm is effective for diagnosing ADHD?
Research shows that the MT1 algorithm, when paired with the MindTension sensor, could aid in diagnosing ADHD. This tool measures muscle reactions to sounds and uses a specialized program to analyze the results. Studies suggest that body signals like skin response, heart rate changes, and skin temperature can help identify ADHD. The MT1 algorithm uses this information to support accurate diagnoses. Early findings indicate it can effectively assist healthcare providers in diagnosing ADHD in young people. Participants in this trial will undergo evaluation with the MT1 algorithm to assess its effectiveness in diagnosing ADHD compared to established clinical methods.12345
Who Is on the Research Team?
Jeffrey Newcorn, MD Professor
Principal Investigator
Director, Division of ADHD and Learning Disorders Icahn School of Medicine at Mount Sinai
Are You a Good Fit for This Trial?
This trial is for children aged 6 to 17 who may have ADHD. They must be willing to follow the study rules and can't have taken stimulants recently, or they must stop them for three days before testing. Kids with ADHD symptoms confirmed by specific assessments are included, while those without any diagnosable disorder on these tests are excluded.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Clinical Assessment
Participants undergo clinical assessment using the MT1 algorithm and standard diagnostic interviews
Follow-up
Participants are monitored for agreement between MT1 output and specialist clinician diagnosis
What Are the Treatments Tested in This Trial?
Interventions
- MT1 Auditory startle response patterns analysis algorithm
Find a Clinic Near You
Who Is Running the Clinical Trial?
MindTension
Lead Sponsor